Two-Hour Creatinine Clearance and Glomerular Filtration Rate Estimated from Serum Cystatin C and Creatinine in the Elderly to Preoperative Period


Introduction: The utility of estimates of glomerular filtration rate based on creatinine and cystatin C serum levels to assess renal function in older surgical patients remains to be determined. Objective: To determine whether 2h-creatinine clearance (CrCl-2h) can be an adequate substitute for glomerular filtration rate estimates obtained by measuring serum cystatin C and creatinine in the elderly at preoperation. Methods: A total of 102 consecutive elder patients undergoing pre-anesthesia evaluation for routine surgeries were included. Study subjects were allocated into three groups: Group 1 (G1)—hypertensive diabetic patients, Group 2 (G2)—hypertensive patients, and Group 3 (G3)—non-hypertensive and non-diabetic patients. Two-hour urine collection was performed and CrCl-2h adjusted for ultrasonic residual bladder volume was estimated. GFR was estimated based on creatinine and cystatin C serum levels. Bland-Altman analysis was used to compare methods. Results: The mean difference between the evaluated methods and CrCl-2h was <15 mL·min-1·1.73 m-2 for Cys-GFR, and >20 mL·min-1·1.73 m-2 for Cr-GFR in all groups. CrCl-2h adjusted for ultrasonic residual bladder volume did not differ from non-adjusted CrCl-2h in none of the groups. Conclusion: Two-hour creatinine clearance was not an adequate substitute for GFR estimates based on creatinine and cystatin C serum levels in older patients at preoperation. The ultrasonic assessment of residual bladder volume had no significant influence on the calculation of two-hour creatinine clearance.

Share and Cite:

L. da Silva, P. Galvão Vianna, M. Takaku, G. Mizubuti and Y. Machado Castiglia, "Two-Hour Creatinine Clearance and Glomerular Filtration Rate Estimated from Serum Cystatin C and Creatinine in the Elderly to Preoperative Period," Open Journal of Nephrology, Vol. 3 No. 4, 2013, pp. 184-188. doi: 10.4236/ojneph.2013.34032.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] S. Klag, P. K. Whelton, B. L. Randall, et al., “Blood Pressure and End-Stage Renal Disease in Men,” The New England Journal of Medicine, Vol. 334, No. 1, 1996, pp. 13-18.
[2] M. C. B. S. Benarab, Y. M. M. Castiglia, P. T. G. Vianna, et al., “Two-Hours Evaluation of Renal Function in the Elderly,” Revista Brasileira de Anestesiologia, Vol. 55, No. 3, 2005, pp. 269-278.
[3] Y,Yi-sun, C. H. Peng, C. K. Lin, et al., “Use of Serum Cystatin C to Detect Early Decline of Glomerular Filtration Rate in Tape 2 Diabetes,” Intern med., Vol. , No. , 2007, pp. 801-806.
[4] J. R. Friedman, D. C. Norman and T. T. Yoshikawa, “Correlation of Estimated Renal Function Parameters Versus 24-Hour Creatinine Clearance in Ambulatory Elderly,” Journal of the American Geriatrics Society, Vol. 37, No. 2, 1989, pp. 145-149.
[5] D. D. Cardenas, E. Kelly, J. N. Krieger, et al., “Residual Urine Volumes in Patients with Spinal Cord Injury: Measurement with a Portable Ultrasound Instrument,” Archives of Physical Medicine and Rehabilitation, Vol. 69, No. 7, 1988, pp. 514-516.
[6] M. Gutierrez, G. S. Perez, E. Banderas-Bravo, et al., “Replacement of 24h Creatinine Clearance by 2-h Creatinine in Intensive Care Unit Patients: A Single-Center Study,” Intensive Care Medicine, Vol. 33, No. 11, 2007, pp. 1900-1906.
[7] N. J. Van Den Noortgate, W. H. Janssens, J. R. Delanghe, et al., “Serum Cystatin C Concentration Compared with Other Markers of Glomerular Filtration Rate in the Old Old,” Journal of the American Geriatrics Society, Vol. 50, No. 7, 2002, pp.1278-1282.
[8] D. W. Cockcroft and M. H. Gault, “Prediction of Creatinine Clearance from Serum Creatinine,” Nephron, Vol. 16, No. 1, 1976, pp. 31-41.
[9] A. Larsson, J. Malm, A. Grubb, et al., “Calculation of Glomerular Filtration Rate Expressed in mL/min from Plasma Cystatin C Values in mg/L,” Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 64, No. 1, 2004, pp. 25-30.
[10] J. M. Bland and D. G. Altman, “Statistical Methods for Assessing Agreement between Two Methods of Clinical Measurement,” The Lancet, Vol. 327, No. 8476, 1986, pp. 307-310.
[11] D. J. Newman, H. Thakkar, R. G. Edwards, et al., “Serum Cystatin C Measured by Automated Immunoassay: A More Sensitive Marker of Changes in GFR than Serum Creatinine,” Kidney International, Vol. 47, No. , 1995, pp. 312-318.
[12] B. Stabuc, L. Vrhovec, M. Stabuc-Silih, et al., “Improved Prediction of Decreased Creatinine Clearance by Serum Cystatin C: Use in Cancer Patients before and during Chemotherap,” Clinical Chemistry, Vol. 1, No. , 2000, pp. 29-34.
[13] D. Fliser and E. Ritz, “Serum Cystatin C Concentration as a Marker of Renal Dysfunction in the Elderly,” American Journal of Kidney Diseases, Vol. 37, No. 1, 2001, pp. 79-83.
[14] E. Coll, A. Botey, L. Alvarez, et al., “Serum Cystatin C as a New Marker for Noninvasive Estimation of Glmerular Filtration Rate and as a Marker for Early Renal Impairment,” American Journal of Kidney Diseases, Vol. 36, No. 1, 2000, pp. 29-34.
[15] T. H. Goldberg and M. S. Fin kelstein, “Difficulties in Estimating Glomerular Filtration Rate in the Elderly,” Archives of Internal Medicine, Vol. 147, No. 8, 1987, pp. 1430-1433.
[16] S. L. Markantonis and E. Kioupaki-Agathokleusous, “Can Two, Four or Eight-Hour Urine Collections after Voluntary Voiding Be Used Instead of Twenty-Four Collections for the Estimation of Creatinine Clearance in Healthy Subjects?” Pharmacy World and Science, Vol. 20, No. 6, 1998, pp. 258-263.

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.